CHDN(CHDN)
CHDN
Q4 2026 EPS Estimate
$1.21
Oct 28, 2026 · Reports after close
Revenue Estimate
$701M
FY2026E EPS$6.95
FY2027E EPS$7.38
Analyst Sentiment
Wall St. Consensus
Buy22 analysts·High coverage
75
Score
22 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
22100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$145.00
+54.7%
Consensus
$145.00
+54.7%
Bull
$145.00
+54.7%
12-Month Target Range22 analysts
$145.00$145.00$145.00
Current $93.71Consensus
Current Price
$93.71
Upside to Consensus
$51.29
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+2.98%
EPS+6.27%
FY2028
Rev+2.90%
EPS+10.69%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $3.03B | $3.12B | $3.21B |
| Low | $3.02B | $3.09B | $3.16B |
| High | $3.04B | $3.13B | $3.25B |
| EBITDA Avg | $1.20B | $1.24B | $1.27B |
| Low | $1.20B | $1.23B | $1.25B |
| High | $1.20B | $1.24B | $1.29B |
| EBIT Avg | $982M | $1.01B | $1.04B |
| Low | $979M | $1.00B | $1.02B |
| High | $985M | $1.01B | $1.06B |
| Net Income Avg | $498M | $528M | $582M |
| Low | $488M | $517M | $561M |
| High | $508M | $539M | $605M |
| EPS Avg | $6.95 | $7.38 | $8.17 |
| Low | $6.83 | $7.24 | $7.86 |
| High | $7.12 | $7.54 | $8.48 |
| Analysts (Rev / EPS) | 8 / 5 | 8 / 5 | 6 / 2 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $701M | $679M | $676M | $1.00B | $734M | $714M | $705M | $1.04B |
| Low | $699M | $674M | $670M | $994M | $727M | $707M | $698M | $1.03B |
| High | $704M | $683M | $687M | $1.02B | $746M | $725M | $716M | $1.05B |
| EBITDA Avg | $278M | $269M | $268M | $398M | $291M | $283M | $280M | $411M |
| Low | $277M | $267M | $266M | $395M | $289M | $281M | $277M | $407M |
| High | $279M | $271M | $272M | $404M | $296M | $288M | $284M | $418M |
| EBIT Avg | $227M | $220M | $219M | $326M | $238M | $232M | $229M | $336M |
| Low | $227M | $219M | $217M | $323M | $236M | $229M | $227M | $333M |
| High | $228M | $222M | $223M | $331M | $242M | $235M | $232M | $341M |
| Net Income Avg | $85M | $76M | $83M | $261M | $88M | $83M | $100M | $272M |
| Low | $82M | $76M | $82M | $258M | $87M | $82M | $99M | $269M |
| High | $91M | $77M | $84M | $266M | $89M | $85M | $102M | $278M |
| EPS Avg | $1.21 | $1.09 | $1.18 | $3.73 | $1.25 | $1.19 | $1.43 | $3.89 |
| Low | $1.17 | $1.08 | $1.17 | $3.69 | $1.24 | $1.18 | $1.41 | $3.84 |
| High | $1.29 | $1.10 | $1.21 | $3.81 | $1.28 | $1.21 | $1.46 | $3.97 |
| Analysts (Rev / EPS) | 7 / 5 | 7 / 5 | 3 / 3 | 3 / 3 | 3 / 3 | 6 / 3 | 5 / 4 | 4 / 4 |